Now Is The Time To Build A Position In Recursion Pharmaceuticals Inc (NASDAQ:RXRX)
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 5.19 million during the last session, with the company’s beta value hitting 0.76. At the close of